Search PubMedSearch

PubMed · 1694434

Flow cytogenetics.

Abstract

Applications of flow karyotype analysis and flow chromosome sorting are being developed and are becoming increasingly relevant to clinical research. Among these applications are the quantitative analysis of chromosomal DNA content changes enabling the detection of minute deletions or unbalanced translocations, the quantitative analysis of aneuploidy for trisomy screening, and the sorting of derivative chromosomes for mapping chromosome breakpoints. Flow karyotyping has been accomplished on samples with clinical relevance including peripheral blood from both children and cancer patients as well as amniotic cell cultures. New techniques in flow cytogenetics to resolve chromosomes by morphology or by DNA sequence hybridizations are assessed for their promise. Although flow karyotyping has not yet developed into an 'automated' karyotyping technique, when used in conjunction with classical cytogenetic techniques, new information of significance to the clinician can be produced.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M F Bartholdi. 1990. Flow cytogenetics.. https://doi.org/10.1159/000163573

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Detection of a single base exchange in PCR-amplified DNA fragments using agarose gel electrophoresis containing bisbenzimide-PEG.

Using PCR fragments of known sequences derived from isolates of two related fungal species, simple submarine electrophoresis in agarose gels containing a bisbenzimide-PEG conjugate (H.A.-Yellow) has been shown to be capable of distinguishing DNA fragments 567 bp long which differ by as little as a single base change. However, only changes affecting bisbenzimide binding sites (which consist of at least four consecutive A/T bases) alter mobility; other changes are ineffective. A second ligand (H.A.-Red) with high G/C specificity is suggested which may be as effective in detecting other sequence changes.

Bisbenzimidazole

Quantification of tumour cell-endothelial cell attachment by 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine (DiI).

Tumour cell attachment to the endothelial cell lining of the circulatory system is of utmost importance in the process of cancer spread. We describe here a method of quantifying tumour cell attachment to an endothelial cell layer in vitro, using the fluorescent carbocyanine dye, 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine (DiI). We show that by incubation of human tumour cells with this fluorochrome, a high degree of fluorescent label can be incorporated into the cells without cytotoxic effects. These labelled tumour cells can then be used in subsequent attachment assays involving confluent human endothelial cell layers and subsequently quantified by using a fluorescent plate reader. Monitoring of this assay by fluorescent microscopy showed no transfer of the dye between tumour and attached endothelial cells. The labelled cells remained fluorescent for more than 3 days with no observable cytotoxicity. We suggest that DiI is of use in an assay system such as this to determine the effects of various factors on tumour cell-endothelial cell attachment.

Bisbenzimidazole